Systemic Therapy for Tumor Control in Metasta...

Dr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new treatment options for patients treated with ADT alone, ADT and an ARPI, ADT and docetaxel, and ADT, an ARPI, a ...  Show more

Dr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover recommendations for therapeutic options across smoldering multiple myeloma, transplant eligible multiple myeloma ...  Show more

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. In this episode, Dr. Diane Reidy-Lagunes is joined by medical oncologist Dr. Dana Rathkopf, radiation oncologist Dr. Sean McBride, and urolo ...  Show more

Drs. Lorraine Provencher and Matthew Emanuel join the show to discuss current nonsurgical management options for glaucoma patients. The panel reviews new topical therapy such as rho kinase (ROCK) inhibitors, injectable therapy, and the role of selective laser trabeculoplasty (SLT ...  Show more

In this episode of The Good GP, host Dr Tim Koh welcomes distinguished guest Professor Chan Cheah, a clinical and laboratory-based haematologist with a special interest in lymphoma. Professor Cheah, who practises at Sir Charles Gairdner Hospital and works with Western Diagnost ...

Go online to PeerView.com/BQF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Neurofibromatosis type 1 (NF-1) is a rare autosomal dominant disorder of the nervous system that is associated with significant morbidity, includin ...  Show more